Back To: Home

CLICK HERE FOR WHAT'S NEW IN:
 




 

Horizon launches gene-engineered bioproduction cell line with flexible licensing model
January 2015
SHARING OPTIONS:

Horizon Discovery
 
Horizon Discovery has shipped its first commercially available engineered CHO cell line for use in manufacturing of therapeutic antibodies. Horizon’s innovative licensing model brings these cutting-edge bioproduction cells within reach of companies of all sizes, reducing timelines and costs associated with the development of large molecule drugs (biotherapeutics).
This latest development is the first step in Horizon’s strategy toward building a comprehensive Good Manufacturing Practice bioproduction cell line platform.
 
Horizon Discovery Group Plc

Back



PAGE UTILITIES


CONTACT US
DDNEWS
478 Bay Street, Suite A213
Midland, Ontario, Canada L4R 1K9
Ph: 888-781-0328 |  Fax: 705-528-0270
 
© Copyright 2020 Old River Publications LLC. All righs reserved.  |  Web site managed and designed by OffWhite.